AI-Powered oxygen device could revolutionize respiratory care

NCT ID NCT06952816

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new AI device called EMILY that automatically adjusts oxygen levels for people with acute or chronic respiratory failure. Researchers will enroll 20 adults in the hospital to see how well the device keeps oxygen in a safe range and how quickly it responds to changes. The goal is to improve patient safety and reduce the need for constant manual adjustments by medical staff.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure Hypoxia respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Fundación Jiménez Díaz

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    RECRUITING

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••